S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NYSE:ITGR

Integer (ITGR) Stock Price, News & Analysis

$116.73
+1.67 (+1.45%)
(As of 03/28/2024 ET)
Today's Range
$115.70
$117.78
50-Day Range
$98.56
$116.22
52-Week Range
$69.40
$118.15
Volume
211,566 shs
Average Volume
291,407 shs
Market Capitalization
$3.90 billion
P/E Ratio
43.39
Dividend Yield
N/A
Price Target
$109.67

Integer MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
6.1% Downside
$109.67 Price Target
Short Interest
Bearish
7.66% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.80mentions of Integer in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
16.29%
From $5.28 to $6.14 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.32 out of 5 stars

Medical Sector

787th out of 939 stocks

Electromedical Equipment Industry

17th out of 20 stocks

ITGR stock logo

About Integer Stock (NYSE:ITGR)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

ITGR Stock Price History

ITGR Stock News Headlines

Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
ITGR Aug 2024 110.000 call
ITGR May 2024 90.000 call
Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
Integer Holdings Corp
Integer: Q4 Earnings Snapshot
Integer Holdings Q4 2023 Earnings Preview
Here's Why Integer (ITGR) is a Strong Momentum Stock
Integer Holdings Corp.
See More Headlines
Receive ITGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
3/29/2024
Next Earnings (Estimated)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Previous Symbol
NASDAQ:ITGR
CUSIP
39153L10
Employees
10,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$109.67
High Stock Price Target
$137.00
Low Stock Price Target
$86.00
Potential Upside/Downside
-9.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

Net Income
$90.65 million
Pretax Margin
6.72%

Debt

Sales & Book Value

Annual Sales
$1.60 billion
Cash Flow
$8.31 per share
Book Value
$45.58 per share

Miscellaneous

Free Float
32,790,000
Market Cap
$3.90 billion
Optionable
Optionable
Beta
1.09
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Joseph W. DziedzicMr. Joseph W. Dziedzic (Age 56)
    President, CEO & Director
    Comp: $2M
  • Mr. Payman Khales (Age 54)
    President of Cardio & Vascular
    Comp: $652.92k
  • Mr. Diron Smith (Age 50)
    Executive VP & CFO
  • Mr. John Harris (Age 64)
    Executive Vice President of Global Operations & Manufacturing Strategy
    Comp: $521.18k
  • Mr. Tom P. Thomas (Age 53)
    VP, Corporate Controller & Principal Accounting Officer
  • Mr. Andrew Senn (Age 42)
    Senior Vice President of Strategy, Business Development & Investor Relations
  • Mr. McAlister C. Marshall II (Age 54)
    Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary
  • Mr. Kirk K. Thor (Age 60)
    Executive VP & Chief Human Resources Officer
    Comp: $689.95k
  • Ms. Margaret Carthy (Age 60)
    Executive VP of Global Quality & Regulatory Affairs
  • Mr. Jim Stephens (Age 50)
    President of Cardiac Rhythm Management & Neuromodulation

ITGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Integer stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ITGR shares.
View ITGR analyst ratings
or view top-rated stocks.

What is Integer's stock price target for 2024?

6 equities research analysts have issued 1-year price targets for Integer's stock. Their ITGR share price targets range from $86.00 to $137.00. On average, they expect the company's stock price to reach $109.67 in the next twelve months. This suggests that the stock has a possible downside of 6.1%.
View analysts price targets for ITGR
or view top-rated stocks among Wall Street analysts.

How have ITGR shares performed in 2024?

Integer's stock was trading at $99.08 at the beginning of 2024. Since then, ITGR shares have increased by 17.8% and is now trading at $116.73.
View the best growth stocks for 2024 here
.

Are investors shorting Integer?

Integer saw a increase in short interest during the month of February. As of February 29th, there was short interest totaling 2,430,000 shares, an increase of 15.7% from the February 14th total of 2,100,000 shares. Based on an average trading volume of 292,600 shares, the days-to-cover ratio is presently 8.3 days. Currently, 7.4% of the company's shares are short sold.
View Integer's Short Interest
.

When is Integer's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our ITGR earnings forecast
.

How were Integer's earnings last quarter?

Integer Holdings Co. (NYSE:ITGR) posted its quarterly earnings data on Thursday, February, 15th. The medical equipment provider reported $1.39 earnings per share for the quarter, topping analysts' consensus estimates of $1.34 by $0.05. The medical equipment provider earned $413.15 million during the quarter, compared to the consensus estimate of $409.04 million. Integer had a net margin of 5.68% and a trailing twelve-month return on equity of 10.80%. The firm's revenue for the quarter was up 10.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.11 EPS.

What guidance has Integer issued on next quarter's earnings?

Integer issued an update on its FY 2024 earnings guidance on Friday, February, 16th. The company provided earnings per share guidance of 5.010-5.430 for the period, compared to the consensus EPS estimate of 5.450. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.

What is Joseph Dziedzic's approval rating as Integer's CEO?

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Who are Integer's major shareholders?

Integer's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.41%), Vanguard Group Inc. (11.38%), Dimensional Fund Advisors LP (6.18%), Franklin Resources Inc. (4.94%), Victory Capital Management Inc. (4.79%) and GW&K Investment Management LLC (1.88%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Donald J Spence, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends
.

How do I buy shares of Integer?

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ITGR) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners